No 10Y consistency score yet for revenue — the year-earlier revenue was zero, negative or too small a base to compare against in 23 of the 40 quarters in the window, leaving 17 comparable quarters; at least 28 are needed.
Valuation vs own 10Y history: P/S 794.5x · 10Y median 669.9x · 59th percentile · as of Oct 6, 2026
Annualized revenue (TTM) · by quarter, last 40
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:05:41.298Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for Atomera Incorporated (ATOM) stock was $4.72 as of Oct 6, 2026, 10:05 AM EDT, up 2.16% from the previous close.
Longer view (total return, dividends reinvested): past 12 months -7.2% · 3-year avg -10.4%/yr · 5-year avg -27.6%/yr
Atomera Incorporated develops, commercializes, and licenses its unique materials, processes, and technologies for the semiconductor sector across North America and the Asia Pacific region. Central to its offerings is the Mears Silicon Technology (MST), a refined, ultra-thin silicon film designed to enhance the transistor channel of CMOS-type devices.
Semiconductors · Los Gatos, CA
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
Next Earnings Date
Oct 27, 2026
21 days away
EPS Estimate
-0.12
Revenue Est.
$100000.00
Last Quarter Results
EPS
$-0.12
vs Estimate
$-0.13
Revenue
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1ATOM | $182.74M | $4.72 | +2.16% | -7.20% | -27.55% | -5.10% | N/A |
| 2CRNT | $194.97M | $2.15 | +0.23% | -9.66% | -8.63% | -0.80% | vs ATOM |
| 3KLTR | $198.49M | $1.32 | +0.00% | -12.53% | -33.70% | N/A | vs ATOM |
| 4GDEV | $201.29M | $11.09 | -4.89% | -66.52% | -29.39% | N/A | vs ATOM |
| 5OSS | $207.07M | $8.36 | +0.36% | +47.42% | +10.71% | N/A | vs ATOM |
| 6EGAN | $156.88M | $5.71 | -4.27% | -39.67% | -10.40% | +6.50% | vs ATOM |
forward FY estimate
N/A
$158000.00
vs Estimate
$100000.00
Consensus Rating
Based on 1 analyst
Average Price Target
$10.00
+111.9% upside
Low
$10.00
Current
$4.72
High
$10.00
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Quarter ending Dec 2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $-0.48 | $-0.48 | $-0.48 | 1 |
| FY 2027 | $-0.40 | $-0.40 | $-0.40 | 1 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $100000.00 | $100000.00 | $100000.00 | 1 |
| Quarter ending Dec 2026 | $100000.00 | $100000.00 | $100000.00 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $300000.00 | $300000.00 | $300000.00 | 1 |
Source: FMP Analyst Consensus Estimates. Forward P/E is unavailable for the current price and estimate observations.
| FY 2027 |
| $1.00M |
| $1.00M |
| $1.00M |
| 1 |
